References
- Leukemia & Lymphoma Society. Acute Myeloid Leukemia [Internet]. 2017. [cited 2018 Apr 24]. Available from: https://www.lls.org/sites/default/files/file_assets/PS32_AML_BookletFINAL_with_insert.pdf
- National Cancer Institute Surveillance, Epidemiology, and End Results program. Cancer stat facts: acute myeloid leukemia (AML) (1992–2015). [Internet]. 2018. [cited 2018 Apr 24]. Available from: https://seer.cancer.gov/statfacts/html/amyl.html
- National Cancer Institute Surveillance, Epidemiology, and End Results Program. SEER Cancer Statistics Review 1975–2014 SEER incidence rates, age-adjusted and age-specific rates, by race and sex [Internet]. 2018. [cited 2018 Apr 24]. Available from: https://seer.cancer.gov/csr/1975_2014/results_single/sect_13_table.13.pdf
- Kumar CC. Genetic abnormalities and challenges in the treatment of acute myeloid leukemia. Genes Cancer. 2011;2:95–107.
- National Comprehensive Cancer Network Clinical practice guidelines in oncology. Acute myeloid leukemia. Version 1 [Internet]. 2018 [cited 2018 Apr 24]. Available from: www.nccn.org/professionals/physician_gls/pdf/aml.pdf
- Anderson P, Benford M, Harris N, et al. Real-world physician and patient behaviour across countries: disease-specific programmes – a means to understand. Curr Med Res Opin. 2008;24:3063–3072.
- Health Information Technology. Health Information Technology Act [Internet]. 2009. [cited 2018 Apr 24]. Available from: https://www.healthit.gov/sites/default/files/hitech_act_excerpt_from_arra_with_index.pdf
- US Department of Health and Human Services. Summary of the HIPAA Privacy Rule [Internet]. May 2003. [cited 2018 Apr 24]. Available from: http://www.hhs.gov/sites/default/files/privacysummary.pdf
- Higgins V, Piercy J, Roughley A, et al. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes. 2016;9:371–380.
- Babineaux SM, Curtis B, Holbrook T, et al. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme. BMJ Open. 2016;6:e010352.
- Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
- Meyers J, Yu Y, Kaye JA, et al. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Appl Health Econ Health Policy. 2013;11:275–286.
- Juliusson G, Antunovic P, Derolf A, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 2009;113:4179–4187.
- Becker H, Marcucci G, Maharry K, et al. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study. JCO. 2010;28:596–604.
- Döhner H, Estey EH, Amadori S, et al. European LeukemiaNet. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453–474.
- Medeiros BC, Satram-Hoang S, Hurst D, et al. Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States. Ann Hematol. 2015;94:1127–1138.
- Ma E, Bonthapally V, Chawla A, et al. An evaluation of treatment patterns and outcomes in elderly patients newly diagnosed with acute myeloid leukemia: a retrospective analysis of electronic medical records from US community oncology practices. Clin Lymphoma Myeloma Leuk. 2016;16:625–636.e3.
- Ossenkoppele G, Löwenberg B. How I treat the older patient with acute myeloid leukemia. Blood. 2015;125:767–774.
- Erba P. Finding the optimal combination therapy for the treatment of newly diagnosed AML in older patients unfit for intensive therapy. Leuk Res. 2015;39:183–191.
- Dechartres A, Chevret S, Lambert J, et al. Inclusion of patients with acute leukemia in clinical trials: a prospective multicenter survey of 1066 cases. Ann Oncol. 2011;22:224–233.
- Hubbard TE, Paradis R. Real-world evidence: a new era for health care innovation. The Network for Excellence in Health Innovation [Internet]. 2015. [cited 2018 Apr 24]. Available from: http://www.nehi.net/writable/publication_files/file/rwe_issue_brief_final.pdf
- Østgård LS, Nørgaard M, Sengeløv H, et al. Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: a national population-based cohort study of Danish intensive chemotherapy patients. Oncotarget. 2016;7:72044–72056.